[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20053357D0 - Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse. - Google Patents

Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.

Info

Publication number
NO20053357D0
NO20053357D0 NO20053357A NO20053357A NO20053357D0 NO 20053357 D0 NO20053357 D0 NO 20053357D0 NO 20053357 A NO20053357 A NO 20053357A NO 20053357 A NO20053357 A NO 20053357A NO 20053357 D0 NO20053357 D0 NO 20053357D0
Authority
NO
Norway
Prior art keywords
myoblasts
culture
culture medium
culture method
medium
Prior art date
Application number
NO20053357A
Other languages
English (en)
Other versions
NO20053357L (no
Inventor
Christian Pinset
Original Assignee
Celogos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celogos filed Critical Celogos
Publication of NO20053357L publication Critical patent/NO20053357L/no
Publication of NO20053357D0 publication Critical patent/NO20053357D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20053357A 2002-12-13 2005-07-11 Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse. NO20053357D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0215827 2002-12-13
PCT/FR2003/003691 WO2004055174A1 (fr) 2002-12-13 2003-12-12 Composition de milieu de culture, procede de culture, et myoblastes ainsi obtenus, et leurs utilisations

Publications (2)

Publication Number Publication Date
NO20053357L NO20053357L (no) 2005-07-11
NO20053357D0 true NO20053357D0 (no) 2005-07-11

Family

ID=32524649

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053357A NO20053357D0 (no) 2002-12-13 2005-07-11 Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.

Country Status (16)

Country Link
US (1) US20060258003A1 (no)
EP (1) EP1572988A1 (no)
JP (1) JP2006509516A (no)
KR (1) KR20050088118A (no)
CN (1) CN1723277A (no)
AU (1) AU2003300585A1 (no)
BR (1) BR0316757A (no)
CA (1) CA2509642A1 (no)
IL (1) IL169115A0 (no)
MX (1) MXPA05006350A (no)
NO (1) NO20053357D0 (no)
NZ (1) NZ540723A (no)
PL (1) PL378334A1 (no)
RU (1) RU2005122030A (no)
WO (1) WO2004055174A1 (no)
ZA (1) ZA200505125B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2029771A4 (en) * 2006-06-12 2010-08-04 Zora Biosciences Oy DIAGNOSTIC METHOD OF MYOPATHY
WO2008018450A1 (fr) * 2006-08-08 2008-02-14 National University Corporation Nagoya University Préparation cellulaire contenant des cellules souches multipotentes provenant d'un tissu adipeux
EP1900810A1 (fr) * 2006-09-15 2008-03-19 Celogos Methode d'extraction et de selection de cellules
US20080208164A1 (en) 2007-02-28 2008-08-28 Innovacell Biotechnologie Gmbh Methods for the treatment of anal incontinence
US20090042296A1 (en) * 2007-03-16 2009-02-12 Marie Callahan Transfection ready eukaryotic cells
AU2008266311A1 (en) * 2007-06-15 2008-12-24 Ethicon, Inc. Tissue fragment compositions for the treatment of incontinence
CN101386836B (zh) * 2007-09-12 2010-11-24 北京清大天一科技有限公司 动物细胞培养基干粉组合物、培养基组合物及其制备方法
ES2360782B1 (es) 2009-07-28 2012-03-12 Grifols, S.A. Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos.
EP2397851B1 (fr) 2010-06-21 2015-01-07 Centre d'Etude des Cellules Souches Méthode de sélection des modulateurs de la synthèse de mévalonate en utilisant des cellules dérivées de cellules pluripotentes humaines
JP2012029623A (ja) * 2010-07-30 2012-02-16 Bio Link Inc 細胞分離用酵素溶液及び細胞分離方法、並びに膵島分離方法
EP2898089A1 (en) * 2012-09-24 2015-07-29 Innovacell Biotechnologie AG Potency assay for skeletal muscle derived cells
EP3081223B1 (en) 2013-12-12 2020-02-19 Samsung Life Public Welfare Foundation Method for promoting generation of stem cell-derived exosome by using thrombin
WO2015091593A1 (en) * 2013-12-18 2015-06-25 Cytoo Device and method for standardizing myoblast differentiation into myotubes
RU2576842C2 (ru) * 2014-02-28 2016-03-10 Общество С Ограниченной Ответственностью "Витацел" Способ получения миобластов, использование биоптата десны, препарат миобластов для лечения патологий мышечной ткани и способ его получения
JP6295341B2 (ja) 2014-03-18 2018-03-14 サムソン ライフ パブリック ウェルフェア ファウンデーション 幹細胞由来エキソソームを有効成分として含む脳炎症性疾患の治療用組成物
US20170204362A1 (en) 2014-06-18 2017-07-20 Medimmune, Llc Cell culture methods and media comprising n-acetylcysteine
KR101960497B1 (ko) * 2016-05-09 2019-03-21 고려대학교 산학협력단 소변 유래 세포 배양용 배지 조성물
WO2019016795A1 (en) * 2017-07-15 2019-01-24 Technion Research & Development Foundation Limited CURVED CARNEY COMPOSITIONS
WO2020165152A1 (en) * 2019-02-13 2020-08-20 Tigenix, S.A.U. Cryopreservation of stem cells
CN112592890A (zh) * 2020-12-17 2021-04-02 江南大学 一种促进肌肉干细胞增殖的方法
US20240182859A1 (en) * 2021-03-29 2024-06-06 Hyupsung University Industry-Academic Cooperation Foundation Medium composition for culturing muscle stem cell comprising curcumin longa, glysin, or insulin for proliferation of muscle stem cell
CN114752590B (zh) * 2022-01-14 2023-09-08 江南大学 一种高效且经济的猪肌肉干细胞的分离方法及其应用
CN117625519A (zh) * 2022-08-12 2024-03-01 江南大学 促肌肉干细胞体外存活和增殖的无胎牛血清培养基及其应用
CN117925509B (zh) * 2024-03-25 2024-06-11 山东三链医疗科技有限公司 一种细胞培养替代血清培养液及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7984498A (en) * 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium

Also Published As

Publication number Publication date
CA2509642A1 (fr) 2004-07-01
AU2003300585A1 (en) 2004-07-09
EP1572988A1 (fr) 2005-09-14
WO2004055174A1 (fr) 2004-07-01
NO20053357L (no) 2005-07-11
ZA200505125B (en) 2006-03-29
MXPA05006350A (es) 2006-02-08
CN1723277A (zh) 2006-01-18
BR0316757A (pt) 2005-10-25
RU2005122030A (ru) 2005-12-20
US20060258003A1 (en) 2006-11-16
KR20050088118A (ko) 2005-09-01
JP2006509516A (ja) 2006-03-23
PL378334A1 (pl) 2006-03-20
IL169115A0 (en) 2007-07-04
NZ540723A (en) 2008-04-30

Similar Documents

Publication Publication Date Title
NO20053357D0 (no) Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.
AU2003274906A8 (en) Double stranded rna structures and constructs, and methods for generating and using the same
DK1436309T3 (da) BGL3-beta-glukosidase og nukleinsyrer kodende derfor
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
DK1455785T3 (da) Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
IT1318319B1 (it) Composizione di gomma, procedimento per produrre la stessa e manicottoutilizzante la composizione di gomma.
DK1668125T3 (da) Modificerede enzymer, fremgangsmåde til fremstilling af modificerede enzymer og anvendelser deraf
NO20052149D0 (no) Vaksine.
BR0312460B1 (pt) suporte sàlido, processo de preparaÇço, e, uso do mesmo.
ITRM20010056A0 (it) Apparecchiatura per la fermentazione di sostanze, in particolare per vinificazione.
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
NL1023109A1 (nl) Samenstel, frame en houder.
IT1321313B1 (it) Piastrella fratturabile per ottenere tozzetti o listelli, e relativometodo.
FI20010221A0 (fi) Menetelmä entsyymin uuttamiseksi
MXPA03007550A (es) Derivados coloporosidos, proceso para su preparacion y su uso.
FI20030627A0 (fi) Menetelmä ja järjestely kaasunpoistossa, sekä niiden käyttö
ITMI20022425A1 (it) Distanziatore e distanziale.
NO20040693L (no) Fermenteringsmetode.
ITPR20030078A1 (it) Flangia, in particolare per tubetti e/o rocche.
ITMC20020021A1 (it) Simulatore di pagaiata per kayac, canoa e dragon-boat.
ITMO20020267A1 (it) Metodo, dispositivo e mezzi di pressatura.
SE0302591D0 (sv) Handling asynchronity, method and associated circuitry
ES1052584Y (es) Cultivador polivalente.
ITPD20030073A1 (it) Telaio per infissi, serramenti e simili, particolarmente per esterni.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application